Second wave pandemic preparedness: procurement principles

24 August 2020

Policy

Policy Roadmap for Medicines Manufacturing Leadership

6 July 2020

Policy

Call for tenders SANTE/2020/C3/29 for the supply of medicinal products used for intensive care patients subject to the novel coronavirus (COVID-19) disease – policy and technical concerns

25 June 2020

Policy

Preparing for a potential second COVID-19 wave. Joint statement by Medicines for Europe and EFPIA with Kearney

22 June 2020

Policy

LESSONS LEARNED FROM COVID-19 – POLICY PAPER

22 June 2020

Policy

Questions and answers on regulatory expectations for medicinal products for human use during the COVID-19 pandemic

10 April 2020

External Resource

Why is Now the Right Time to Modernise the Eu Variations System?

30 January 2020

Report

AMR Industry Alliance 2020 Progress Report

16 January 2020

Report

Biosimilars in the EU – Information guide for healthcare professionals – now available in 23 languages

29 October 2019

External Resource

Unofficial Ukrainian translation (PDF/600 KB) (PDF/600 KB) English (PDF/1.85 MB) […]

Overarching recommendations for improved access to generic and biosimilar medicines in the hospital setting

7 October 2019

Report